2022 Agenda

Thursday, January 27, 2022

1:00 PM – 5:10 PM mCRC
1:00 PM – 1:15 PM Introduction and Cases
1:20 PM – 1:35 PM Current mCRC Paradigms – Dr. Benjamin Weinberg, Washington, DC
1:35 PM – 1:40 PM Questions & Answers
1:40 PM – 1:55 PM Resection and Ablation for Metastatic Colon Cancer to the Liver –Dr. Jean-Nicolas Vauthey, Houston, TX
1:55 PM – 2:00 PM Questions & Answers
2:00 PM – 2:15 PM Combining Y90 and Systemic Therapies: Updates and Cautions- Dr. Andrew Kennedy, Nashville, TN
2:15 PM – 2:20 PM Questions & Answers
2:20 PM – 2:55 PM Panel: What Locoregional Therapy and When?
2:55 PM – 3:00 PM Questions & Answers
3:00 PM – 3:10 PM Refreshment Break
3:15 PM – 3:30 PM Biomarker Testing for mCRC and Implications for Liver Directed Therapies- Dr. Benjamin Weinberg, Washington, DC
3:30 PM – 3:35 PM Questions & Answers
3:35 PM – 3:50 PM Is Embolotherapy still Relevant in mCRC? – Dr. Narayanan Govindarajan, Miami, FL
3:50 PM – 3:55 PM Questions & Answers
3:55 PM – 4:10 PM Optimization of Resection: Mgt of Synchronous Metastatic from Colorectal Cancer – Dr. Jean-Nicolas Vauthey, Houston, TX
4:10 PM – 4:15 PM Questions & Answers
4:15 PM – 4:30 PM Transplant, Liver Function and the Era of Immunooncology – Dr. Vladimir Marquez, Vancouver, BC
4:30 PM – 4:35 PM Questions & Answers
4:35 PM – 5:10 PM Panel Cases
5:10 PM – 5:15 PM Questions & Answers
5:15 PM – 7:30 PM SHOW Welcome Reception (Dinner)

Friday, January 28, 2022

7:30 AM – 11:55 AM

HCC Part 1 – Evidence

7:30 AM – 7:45 AM Introduction and Cases
7:45 AM – 7:50 AM Questions & Answers
7:50 AM – 8:05 AM Review of HCC and Embolotherapy: The Last 10 years- Dr. David Liu, Vancouver, BC
8:05 AM – 8:10 AM Questions & Answers
8:10 AM – 8:25 AM Where does Transplant Fit? Criteria and Controversies – Dr. Ian McGilvray, Toronto, ON
8:25 AM – 8:30 AM Questions & Answers
8:30 AM – 8:45 AM Level 1 Evidence for Systemic Therapy in HCC: What Have We Learned – Dr. Howard Lim, Vancouver, BC
8:45 AM – 8:50 AM Questions & Answers
8:50 AM – 9:05 AM Technology Updates in Radiation Therapy for Hepatobiliary Tumors – Dr. Navesh Sharma, Penn State, PA
9:05 AM – 9:10 AM Questions & Answers
9:10 AM – 9:45 AM Panel: Mitigating Upstream and Downstream Toxicity
9:45 AM – 9:50 AM Questions & Answers
9:50 AM – 9:55 AM Coffee Break
10:00 AM- 10:15 AM Locoregional and Systemic Options for Downstaging HCC to Resection or Transplant- Dr. Robert Lewandowski, Chicago, IL
10:15 AM – 10:20 AM Questions & Answers
10:20 AM – 10:35 AM Curative Intent Therapies: Surgical Edition – Dr. Ian McGilvray, Toronto, ON
10:35 AM – 10:40 AM Questions & Answers
10:40 AM – 10:55 AM Curative Intent Therapies: IR Edition- Dr. Robert Lewandowski, Chicago, IL
10:55 AM – 11:00 AM Questions & Answers
11:00 AM – 11:15 AM MDT in HCC: from the Med Onc Perspective –Dr. Howard Lim, Vancouver, BC
11:15 AM – 11:20 AM Questions & Answers
11:20 AM – 11:35 AM Hepatitis and HCC from a Hepatology Perspective – Dr. Vladimir Marquez, Vancouver, BC
11:35 AM – 11:40 AM Questions & Answers
11:40 AM – 11:55 AM Management of Liver Disease: Ascites, Portal Hypertension, Biliaryobstruction – Dr. Jason Wong, Calgary, AB
11:55 AM – 12:00 PM Questions & Answers
12:00 PM – 1:00 PM Lunch
1:00PM – 5:10PM Pancreas
1:00 PM – 1:15 PM Introduction and Cases
1:15 PM – 1:20 PM Questions & Answers
1:20 PM – 1:35 PM Pancreatic Cancer: State of the Union – Dr. Daniel Renouf, Vancouver, BC
1:35 PM – 1:40PM Questions & Answers
1:40 PM – 1:55 PM Current State of the Art: External Beam Radiotherapy for Pancreas Carcinoma – Dr. Navesh K. Sharma, Penn State, PA
1:55 PM – 2:00 PM Questions & Answers
2:00 PM – 2:15 PM Surgical Resection and Curative Intent Patient Optimization – Dr. Mark Truty, Rochester, MN
2:15 PM – 2:20 PM Questions & Answers
2:20 PM – 2:35 PM IR, IRE, PAI: Current and Future Roles for IR in Pancreatic Cancer – Dr. Narayanan Govindarajan, Miami, FL
2:35 PM – 2:40 PM Questions & Answers
2:40 PM – 2:55 PM Surgical Resection for Borderline Resectable/Locally Advanced Pancreas Cancer – Dr. Mark Truty, Rochester, MN
2:55 PM – 3:00 PM Questions & Answers
3:00 PM – 3:10 PM Refreshment Break
3:15 PM – 3:30 PM Pancreatic Cancer: The Multidisciplinary Team – Dr. Daniel Renouf, Vancouver, BC
3:30 PM – 3:35 PM Questions & Answers
3:35 PM – 3:50 PM External Beam Radiation & Y90: Safety, Sequence & Recommendations – Dr. Kyle Cuneo, Ann Arbor, MI
3:50 PM- 3:55 PM Questions & Answers
3:55 PM – 4:30 PM Panel: Complex Surgical Reconstruction When, How and Why
4:30 PM – 4:35 PM Questions & Answers
4:35 PM – 5:10 PM Panel Cases
5:10 PM – 5:15 PM Questions & Answers
5:15 PM – 5:20 PM Closing Remarks

Saturday, January 29, 2022

7:30 AM – 11:55 AM

HCC Part 2 – Consensus and Sequencing

7:30 AM – 7:45 AM Introduction
7:50 AM – 8:05 AM Surgical HCC Consensus Statements HCC- Dr. Peter Kim, Vancouver, BC
8:05 AM – 8:10 AM Questions & Answers
8:10 AM – 8:25 AM Med Onc Consensus Statements – Dr. Howard Lim, Vancouver, BC
8:25 AM – 8:30 AM Questions & Answers
8:30 AM – 8:45 AM Addressing the Clinical Unmet Needs in HCC – Dr. David Liu, Vancouver, BC
8:45 AM – 8:50 AM Questions & Answers
8:50 AM – 9:25 AM Panel: Sequencing and Timing of Systemic vs LRT
9:25 AM – 9:30 AM Questions & Answers
9:30 AM – 9:45 AM CAIR Consensus Statement – Dr. Jason Wong, Calgary, AB
9:45 AM – 9:50 AM Questions & Answers
9:50 AM – 9:55 AM Refreshment Break
10:00 AM- 10:35 AM Panel: Adjuncts to Surgery and Getting to Cure
10:35 AM – 10:40 AM Questions & Answers
10:40 AM – 10:55 AM Current State of the Art: External Beam Radiotherapy for Hepatocellular Carcinoma – Dr. Kyle Cuneo, Ann Arbor, MI
10:55 AM – 11:00 AM Questions & Answers
11:00 AM – 11:15 AM Curative Intent Therapies: IR Edition- Dr. Robert Lewandowski, Chicago, IL
11:15 AM – 11:20 AM Questions & Answers
11:20 AM – 11:55 AM Panel Cases
11:55 AM – 12:00 PM Questions & Answers
12:00 PM – 12:05 PM Final Comments and Close